Literature DB >> 19472920

Usefulness of heart rate variability as a predictor of sudden cardiac death in muscular dystrophies.

L Politano1, A Palladino, G Nigro, M Scutifero, V Cozza.   

Abstract

Sudden cardiac death, or cardiac arrest, is a major health problem, causing about 166,200 deaths each year among adults in the United States. It may be caused by almost all known heart diseases. Most cardiac arrests occur when the diseased heart begins to exhibit rapid and/or chaotic activity, such as ventricular tachycardia or fibrillation. Some are due to extreme slowing of the heart. All these events are called life-threatening arrhythmias. Arrhythmogenic cardiomyopathy is a frequent feature in several muscular dystrophies with a potential risk of cardiac sudden death. Among the measures able to predict the propensity to develop life-threatening arrhythmias, heart rate variability is an accepted non invasive measurement of cardiac autonomic modulation. The use of heart rate variability to measure the extent of changes in autonomic nervous system is an established risk stratification procedure in different diseases. In fact numerous studies have demonstrated the positive prognostic power of altered heart rate variability values to predict all-cause mortality, cardiac events, sudden cardiac death and heart transplantation. Usefulness of heart rate variability as a predictor of sudden cardiac death in muscular dystrophies has been reviewed.

Entities:  

Mesh:

Year:  2008        PMID: 19472920      PMCID: PMC2858940     

Source DB:  PubMed          Journal:  Acta Myol        ISSN: 1128-2460


  36 in total

1.  Impairment of cardiac autonomic function in patients with Duchenne muscular dystrophy: relationship to myocardial and respiratory function.

Authors:  G A Lanza; A Dello Russo; V Giglio; L De Luca; L Messano; C Santini; E Ricci; A Damiani; G Fumagalli; G De Martino; F Mangiola; F Bellocci
Journal:  Am Heart J       Date:  2001-05       Impact factor: 4.749

2.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Authors: 
Journal:  Eur Heart J       Date:  1996-03       Impact factor: 29.983

3.  Autonomic nervous system imbalance and left ventricular systolic dysfunction as potential candidates for arrhythmogenesis in Becker muscular dystrophy.

Authors:  V Ducceschi; G Nigro; B Sarubbi; L I Comi; L Politano; V R Petretta; S Nardi; N Briglia; L Santangelo; G Nigro; A Iacono
Journal:  Int J Cardiol       Date:  1997-05-23       Impact factor: 4.164

4.  [Arrhythmias and heart rate variability in Duchenne and Becker muscular dystrophy].

Authors:  Zivile Katlioriene; Vytautas Zabiela
Journal:  Medicina (Kaunas)       Date:  2002       Impact factor: 2.430

5.  Cardiovascular autonomic control in Becker muscular dystrophy.

Authors:  G Vita; R Di Leo; C De Gregorio; A Papalia; C Rodolico; S Coglitore; C Messina
Journal:  J Neurol Sci       Date:  2001-05-01       Impact factor: 3.181

6.  Decreased heart rate variability and its association with increased mortality after acute myocardial infarction.

Authors:  R E Kleiger; J P Miller; J T Bigger; A J Moss
Journal:  Am J Cardiol       Date:  1987-02-01       Impact factor: 2.778

7.  Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control.

Authors:  S Akselrod; D Gordon; F A Ubel; D C Shannon; A C Berger; R J Cohen
Journal:  Science       Date:  1981-07-10       Impact factor: 47.728

8.  Heart rate variability for risk stratification of life-threatening arrhythmias. American College of Cardiology Cardiovascular Technology Assessment Committee.

Authors: 
Journal:  J Am Coll Cardiol       Date:  1993-09       Impact factor: 24.094

9.  Left ventricular function and perfusion in Becker's muscular dystrophy.

Authors:  L Mansi; L Pace; L Politano; P F Rambaldi; F Di Gregorio; P Raia; V R Petretta; G Nigro
Journal:  J Nucl Med       Date:  1997-04       Impact factor: 10.057

10.  Assessment of cardiovascular autonomic function in myotonic dystrophy type 2 (DM2/PROMM).

Authors:  Peter Flachenecker; Christiane Schneider; Simone Cursiefen; Kenneth Ricker; Klaus V Toyka; Karlheinz Reiners
Journal:  Neuromuscul Disord       Date:  2003-05       Impact factor: 4.296

View more
  19 in total

1.  Chronic oral administration of Ang-(1-7) improves skeletal muscle, autonomic and locomotor phenotypes in muscular dystrophy.

Authors:  Rasna Sabharwal; Michael Z Cicha; Ruben D M Sinisterra; Frederico B De Sousa; Robson A Santos; Mark W Chapleau
Journal:  Clin Sci (Lond)       Date:  2014-07       Impact factor: 6.124

Review 2.  Autonomic, locomotor and cardiac abnormalities in a mouse model of muscular dystrophy: targeting the renin-angiotensin system.

Authors:  Rasna Sabharwal; Mark W Chapleau
Journal:  Exp Physiol       Date:  2013-12-13       Impact factor: 2.969

Review 3.  Applications of Advanced Imaging in Cardiac Electrophysiology.

Authors:  Mrinal Yadava; Michael D Shapiro
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-11

Review 4.  Heart transplantation in patients with dystrophinopathic cardiomyopathy: Review of the literature and personal series.

Authors:  Andrea Antonio Papa; Paola D'Ambrosio; Roberta Petillo; Alberto Palladino; Luisa Politano
Journal:  Intractable Rare Dis Res       Date:  2017-05

5.  Developmental Changes in the ECG of a Hamster Model of Muscular Dystrophy and Heart Failure.

Authors:  Thomas G Hampton; Ajit Kale; Scott McCue; Hemmi N Bhagavan; Case Vandongen
Journal:  Front Pharmacol       Date:  2012-05-18       Impact factor: 5.810

6.  The effect of atrial preference pacing on atrial fibrillation electrophysiological substrate in Myotonic Dystrophy type 1 population.

Authors:  Vincenzo Russo; Gerardo Nigro; Federica DI Meo; Andrea Antonio Papa; Nadia Della Cioppa; Riccardo Proietti; Maria Giovanna Russo; Raffaele Calabrò; Luisa Politano
Journal:  Acta Myol       Date:  2014-12

Review 7.  The heart and cardiac pacing in Steinert disease.

Authors:  Gerardo Nigro; Andrea Antonio Papa; Luisa Politano
Journal:  Acta Myol       Date:  2012-10

8.  Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients.

Authors:  Luigia Passamano; Antonella Taglia; Alberto Palladino; Emanuela Viggiano; Paola D'Ambrosio; Marianna Scutifero; Maria Rosaria Cecio; Vito Torre; Francesco DE Luca; Esther Picillo; Orlando Paciello; Giulio Piluso; Gerardo Nigro; Luisa Politano
Journal:  Acta Myol       Date:  2012-10

9.  Autonomic regulation in muscular dystrophy.

Authors:  Corrado Angelini; Rita Di Leo; Paola Cudia
Journal:  Front Physiol       Date:  2013-09-20       Impact factor: 4.566

10.  The link between stress disorders and autonomic dysfunction in muscular dystrophy.

Authors:  Rasna Sabharwal
Journal:  Front Physiol       Date:  2014-01-29       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.